YG Entertainment, undervalued compared to competitors... Maintain 'Buy' opinion (NH Investment & Securities)

Reporter Kim Jisun / approved : 2023-01-19 09:04:21
  • -
  • +
  • 인쇄
This article is translated by AI company Flitto and Alhpabiz neural machine translation technology

[Alphabiz=(Chicago) Reporter Kim Jisun] NH Investment & Securities maintained its target stock price of 77,000 won and its "buy" opinion on YG Entertainment. The contract of girl group BLACKPINK is expected to maintain solid performance for the time being amid undervalued stock prices ahead of its maturity this year.

NH Investment & Securities said, "Since the issue related to Yang Hyun-seok was resolved at the end of December, the overall business has accelerated," adding, "It is detected that we are trying to clean up the lineup of some artists and accelerate the progress of projects centered on major artists."

NH Investment & Securities also judged that it is a section that relieves the dependence on a single artist, saying, "The launching teaser for the new girl group 'Baby Monster' was unveiled earlier this month, and G-Dragon himself expressed his willingness to resume his solo career by the end of this year."

NH Investment & Securities recently saw YG Entertainment's stock price undervalued. NH Investment & Securities said, "There is various momentum, but the company's stock price is still undervalued compared to its competitors," adding, "It reflects related concerns as Black Pink's contract expires in August."

However, NH Investment & Securities said, "Considering the actual benefits of both artists and companies, it is more likely that the renewal of the contract will proceed smoothly," and stressed, "It is time to put down excessive concerns."

According to YG Entertainment's consolidated performance in the fourth quarter of 2022, sales rose 64 percent year-on-year to 145.5 billion won and operating profit rose 74 percent to 2.3 billion won, which is expected to meet the consensus (average stock market forecast).

 

 

Alphabiz Reporter Kim Jisun(stockmk2020@alphabiz.co.kr)

주요기사

[Exclusive] Samsung Electronics Passes NVIDIA’s HBM3E 12-High Qualification Test, Secures Supply Deal2025.09.19
Civic Groups File Complaint Against Baemin and Coupang Eats Over Alleged Misleading “One-Person Free Delivery” Promotions2025.09.19
KT Confirms Additional Victims in Unauthorized Micro-Payment Case, Faces Criticism Over Initial Response2025.09.19
KFTC Grants Conditional Approval for Joint Venture Between Shinsegae Group and Alibaba Group2025.09.19
Supreme Court Rules in Favor of NTS on U.S. Unregistered Patent Royalties2025.09.19
뉴스댓글 >

건강이 보이는 대표 K Medical 뉴스

HEADLINE

PHOTO

많이 본 기사